| ID | 1617 |
|---|
| No | 1617 |
|---|
| Brand Name | ALISERPATINIB |
|---|
| Ingredients | SELPERCATINIB 40 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | 120 CAPSULES/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON SMALL CELL LUNG CANCER WITH A REARRANGED DURING TRANSFECTION GENE FUSION |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | BLUE CAPSULE CONTAINS WHITE POWDERS |
|---|
| Note | |
|---|
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 L 1233/24 |
|---|
| FDD Registration Date | 14/11/2024 |
|---|
| Expiry Date | 13/11/2029 |
|---|
